| Synthetic lethal interaction of SHOC2 depletion with MEK inhibition in RAS-driven cancers R Sulahian, JJ Kwon, KH Walsh, E Pailler, TL Bosse, M Thaker, ... Cell reports 29 (1), 118-134. e8, 2019 | 72 | 2019 |
| Lysibodies are IgG Fc fusions with lysin binding domains targeting Staphylococcus aureus wall carbohydrates for effective phagocytosis A Raz, A Serrano, C Lawson, M Thaker, T Alston, S Bournazos, ... Proceedings of the National Academy of Sciences 114 (18), 4781-4786, 2017 | 28 | 2017 |
| SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization C Dai, JP Rennhack, TE Arnoff, M Thaker, ST Younger, JG Doench, ... Cell reports 36 (4), 2021 | 23 | 2021 |
| Lysostaphin lysibody leads to effective opsonization and killing of methicillin-resistant Staphylococcus aureus in a murine model A Raz, A Serrano, M Thaker, T Alston, VA Fischetti Antimicrobial Agents and Chemotherapy 62 (10), 10.1128/aac. 01056-18, 2018 | 21 | 2018 |
| Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy KM Campbell, M Thaker, E Medina, A Kalbasi, A Singh, A Ribas, ... Journal for immunotherapy of cancer 10 (3), 2022 | 6 | 2022 |
| Establishment and validation of pheochromocytoma organoids for high-throughput drug screening M Calucho, ZM Cheng, HTL Nguyen, AA Shihabi, H Gonzalez-Cantu, ... Cancer Research 83 (7_Supplement), 195-195, 2023 | 2 | 2023 |
